medigraphic.com
Colegio de Medicina Interna de México.

2019, Number 5

<< Back Next >>

Med Int Mex 2019; 35 (5)

Peripartum cardiomyopathy: An undervalued disease

Herrera-Morales BE, Lara-Cruz J, Arellano-Ramírez A

Language: Spanish
References: 12
Page: 819-826
PDF size: 503.80 Kb.


ABSTRACT

Pregnancy is a state that imposes a real challenge for the maternal cardiovascular system. There is a cardiac remodeling, which along with an increase in myocardial mass, in left ventricular size and decreased myocardial contractility aggravated by changes in pregnancy, can condition acute heart failure during the peripartum period. Peripartum cardiomyopathy is when the systolic function of the left ventricle and the symptoms of heart failure occur in the last month of pregnancy and in the five months after delivery with an incidence ranging from 1/1300 to 1/15,000 pregnancies. This paper reports the case of a 26-year-old female patient, who had a history of congenital cataract, with normal pregnancy and eutocic delivery; during the puerperium patient showed dyspnea, hypoperfusion data and pulmonary and cardiac ultrasonographic evaluation of peripartum dilated cardiomyopathy, being transferred at a third level, where despite intensive multidisciplinary treatment, the patient died. Peripartum cardiomyopathy is an undervalued disease that has a high maternal and perinatal mortality; however, a timely detection can improve treatment and prognosis. The purpose of this case report is to demonstrate the importance of early detection of a poorly diagnosed entity, such as peripartum cardiomyopathy.


REFERENCES

  1. Pérez A, Linarte M, Díaz de León M, Carrillo R, Briones J. Monitoreo hemodinámico no invasivo y mínimamente invasivo en la paciente obstétrica grave. Med Crit 2017;31(5):275-284.

  2. Márquez H, Yáñez L, Rivera JL, López D, Almeida E. Análisis demográfico de una clínica de cardiopatías congénitas del Instituto Mexicano del Seguro Social, con interés en el adulto. Arch Cardiol Mex 2017;S1405-9940(17)30108-8. DOI: 10.1016/j.acmx.2017.09.003.

  3. Bauersachs J, Arrigo M, et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail. 2016;9:1096-105. doi: 10.1002/ejhf.586.

  4. Arany Z, Elkayam U. Peripartum cardiomyopathy. Circulation 2016;133:1397-1409. doi: 10.1161/CIRCULATIONAHA. 115.020491.

  5. Kao DP, Hsich E, Lindenfeld J. Characteristics, adverse events, and racial differences among delivering mothers with peripartum cardiomyopathy. JACC Heart Fail 2013;1(5):409-416. DOI: 10.1016/j.jchf.2013.04.011.

  6. Polanía A D, Navarrete H S. Miocardiopatía periparto. Insuficiencia Cardiaca 2009;4(4):177-183.

  7. Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol 2014;11(6):364-70. doi: 10.1038/nrcardio.2014.37.

  8. Kim M, Shin M. Practical management of peripartum cardiomyopathy. Korean J Intern Med 2017;32:393-403. doi: 10.3904/kjim.2016.360.

  9. Fett JD. Peripartum cardiomyopathy: challenges in diagnosis and management. Exp Rev Cardiovasc Ther 2016 Sept;14(9):1035-1041. doi: 10.1080/14779072.2016.1199273.

  10. Hilfiker-Kleiner D, et al. Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 2015;36:1090-1097. doi: 10.1093/eurheartj/ehv009.

  11. Blauwet LA, Cooper LT. Diagnosis and management of peripartum cardiomyopathy. Heart 2011;97:1970-81. doi: 10.1136/heartjnl-2011-300349.

  12. Lim CP, Sim DK. Peripartum cardiomyopathy: experience in an Asian tertiary centre. Singapore Med J. 2013;54:24-7. DOI: 10.11622/smedj.2013006.




2020     |     www.medigraphic.com